# Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

> **NCT01135589** · PHASE4 · UNKNOWN · sponsor: **Asan Medical Center** · enrollment: 145 (estimated)

## Conditions studied

- Neutropenia
- Hematopoietic Stem Cell Transplantation
- Invasive Fungal Disease

## Interventions

- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT01135589
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2010-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01135589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01135589, "Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01135589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*